oral glp-1 Lilly's Foundayo Outperforms Oral Semaglutide in Phase 3 Type 2 Diabetes Trial Clinically backed oral GLP Oral GLP-1s and injectable GLP-1s

As of this writing, the FDA has not yet formally published the updated Category 2 list following Secretary Kennedy's February 27, 2026 announcement

GSH is implicated in inducing autophagy, where low GSH levels serve as a signal activating autophagy as an adaptive stress response (101)

Here's the case a thoughtful clinician might make against subcutaneous glutathione administration: Argument 1: Absorption variability is higher than IM

ALCAR helps transport fatty acids into the mitochondria (the cells power plants), where they can be used to produce energy

Problem one: the half-life is measured in minutes Kato and colleagues developed an enzyme immunoassay for DSIP and used it to measure clearance in animals given intravenous DSIP